CHF10073 low dose
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Chiesi Farmaceutici S.p.A.
Overview
CHF10073 low dose is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
CHF10073 low dose clinical trials
Explore related
Medical disclaimer. This page summarizes research about CHF10073 low dose for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.